{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:14:41Z","timestamp":1793826881290,"version":"4.6.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23NS110980"],"award-info":[{"award-number":["K23NS110980"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["Student Scholarships in Cardiovascular Disease"],"award-info":[{"award-number":["Student Scholarships in Cardiovascular Disease"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["Stroke"],"award-info":[{"award-number":["Stroke"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12028-025-02338-6","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T17:16:04Z","timestamp":1755882964000},"page":"842-852","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of Nimodipine-Induced Blood Pressure Reductions on Cerebral Autoregulation and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9173-1065","authenticated-orcid":false,"given":"Kaitlyn A.","family":"Stoehr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bartolome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sithmi","family":"Jayasundara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pwint","family":"Thinzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Magid-Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena M.","family":"O\u2019Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"de Havenon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Hebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Matouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin N.","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily J.","family":"Gilmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Ortega-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9711-3340","authenticated-orcid":false,"given":"Nils H.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"issue":"7","key":"2338_CR1","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.1161\/STR.0000000000000436","volume":"54","author":"BL Hoh","year":"2023","unstructured":"Hoh BL, Ko NU, Amin-Hanjani S, et al. Guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American heart association\/American stroke association. Stroke. 2023;54(7):e314\u201370.","journal-title":"Stroke"},{"key":"2338_CR2","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1038\/s41467-024-46015-2","volume":"15","author":"S Thilak","year":"2024","unstructured":"Thilak S, Brown P, Whitehouse T, et al. Diagnosis and management of subarachnoid haemorrhage. Nat Commun. 2024;15:1850.","journal-title":"Nat Commun"},{"issue":"1","key":"2338_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s12028-023-01747-9","volume":"39","author":"VA Shah","year":"2023","unstructured":"Shah VA, Gonzalez LF, Suarez JI. Therapies for delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2023;39(1):36\u201350.","journal-title":"Neurocrit Care"},{"issue":"11","key":"2338_CR4","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1056\/NEJM198303173081103","volume":"308","author":"GS Allen","year":"1983","unstructured":"Allen GS, Ahn HS, Preziosi TJ, et al. Cerebral arterial spasm \u2013 a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med. 1983;308(11):619\u201324.","journal-title":"N Engl J Med"},{"key":"2338_CR5","first-page":"1","volume":"3","author":"SD Mees","year":"2007","unstructured":"Mees SD, Rinkel GJ, Feigin VL, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007;3:1\u201342.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6674","key":"2338_CR6","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/bmj.298.6674.636","volume":"298","author":"JD Pickard","year":"1989","unstructured":"Pickard JD, Murray GD, Illingworth R, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ. 1989;298(6674):636\u201342.","journal-title":"BMJ"},{"key":"2338_CR7","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s12028-012-9670-8","volume":"16","author":"A Choi","year":"2012","unstructured":"Choi A, Ko S-B, Chen H, et al. Acute effects of nimodipine on cerebral vasculature and brain metabolism in high grade subarachnoid hemorrhage patients. Neurocrit Care. 2012;16:363\u20137.","journal-title":"Neurocrit Care"},{"issue":"1","key":"2338_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s12028-023-01760-y","volume":"39","author":"V Rass","year":"2023","unstructured":"Rass V, Kindl P, Lindner A, et al. Blood pressure changes in association with nimodipine therapy in patients with spontaneous subarachnoid hemorrhage. Neurocrit Care. 2023;39(1):104\u201315.","journal-title":"Neurocrit Care"},{"issue":"1","key":"2338_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12028-023-01713-5","volume":"39","author":"MM Treggiari","year":"2023","unstructured":"Treggiari MM, Rabinstein AA, Busl KM, et al. Guidelines for the neurocritical care management of aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2023;39(1):1\u201328.","journal-title":"Neurocrit Care"},{"issue":"8","key":"2338_CR10","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.04.024","volume":"28","author":"A Hajizadeh Barfejani","year":"2019","unstructured":"Hajizadeh Barfejani A, Rabinstein AA, Wijdicks EFM, Clark SL. Poor utilization of nimodipine in aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc Dis. 2019;28(8):2155\u20138.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"2338_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10143-023-02273-0","volume":"47","author":"C Ditz","year":"2024","unstructured":"Ditz C, Matone MV, Schwachenwald B, K\u00fcchler J. Risks of nimodipine dose reduction during the high-risk period for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Neurosurg Rev. 2024;47(1):37.","journal-title":"Neurosurg Rev"},{"issue":"1","key":"2338_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s12028-015-0230-x","volume":"25","author":"N Sandow","year":"2016","unstructured":"Sandow N, Diesing D, Sarrafzadeh A, Vajkoczy P, Wolf S. Nimodipine dose reductions in the treatment of patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2016;25(1):29\u201339.","journal-title":"Neurocrit Care"},{"key":"2338_CR13","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.3171\/2018.11.JNS182891","volume":"132","author":"A Pa\u013ea","year":"2019","unstructured":"Pa\u013ea A, Schick J, Klein M, et al. The influence of nimodipine and vasopressors on outcome in patients with delayed cerebral ischemia after spontaneous subarachnoid hemorrhage. J Neurosurg. 2019;132:1096\u2013104.","journal-title":"J Neurosurg"},{"issue":"21","key":"2338_CR14","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1212\/WNL.0000000000002696","volume":"86","author":"GA Santos","year":"2016","unstructured":"Santos GA, Petersen N, Zamani AA, et al. Pathophysiologic differences in cerebral autoregulation after subarachnoid hemorrhage. Neurology. 2016;86(21):1950\u20136.","journal-title":"Neurology"},{"key":"2338_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-3-319-22533-3_40","volume-title":"Intracranial pressure and brain monitoring XV","author":"KP Budohoski","year":"2016","unstructured":"Budohoski KP, Czosnyka M, Smielewski P, et al. Monitoring cerebral autoregulation after subarachnoid hemorrhage [Internet]. In: Ang B-T, editor., et al., Intracranial pressure and brain monitoring XV. Cham: Springer International Publishing; 2016. p. 199\u2013203."},{"issue":"10","key":"2338_CR16","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1161\/STROKEAHA.119.026282","volume":"50","author":"A Silverman","year":"2019","unstructured":"Silverman A, Kodali S, Strander S, et al. Deviation from personalized blood pressure targets is associated with worse outcome after subarachnoid hemorrhage. Stroke. 2019;50(10):2729.","journal-title":"Stroke"},{"key":"2338_CR17","doi-asserted-by":"publisher","first-page":"e853","DOI":"10.1016\/j.wneu.2019.02.188","volume":"126","author":"Z Yu","year":"2019","unstructured":"Yu Z, Zheng J, Ma L, Li H, You C, Jiang Y. Predictive value of cerebral autoregulation impairment for delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a meta-analysis. World Neurosurgery. 2019;126:e853\u20139.","journal-title":"World Neurosurgery"},{"key":"2338_CR18","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3389\/fneur.2019.01161","volume":"10","author":"C Fischer","year":"2019","unstructured":"Fischer C, Goldberg J, Vulcu S, et al. Nimodipine-induced blood pressure changes can predict delayed cerebral ischemia. Front Neurol. 2019;10:1161.","journal-title":"Front Neurol"},{"issue":"4","key":"2338_CR19","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"2338_CR20","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1001\/jamaneurol.2019.2120","volume":"76","author":"NH Petersen","year":"2019","unstructured":"Petersen NH, Silverman A, Wang A, et al. Association of personalized blood pressure targets with hemorrhagic transformation and functional outcome after endovascular stroke therapy. JAMA Neurol. 2019;76(10):1256\u20138.","journal-title":"JAMA Neurol"},{"issue":"10","key":"2338_CR21","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1161\/STROKEAHA.107.485706","volume":"38","author":"KM Brady","year":"2007","unstructured":"Brady KM, Lee JK, Kibler KK, et al. Continuous time-domain analysis of cerebrovascular autoregulation using near-infrared spectroscopy. Stroke. 2007;38(10):2818\u201325.","journal-title":"Stroke"},{"issue":"1","key":"2338_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s12028-008-9140-5","volume":"10","author":"LA Steiner","year":"2009","unstructured":"Steiner LA, Pfister D, Strebel SP, Radolovich D, Smielewski P, Czosnyka M. Near-infrared spectroscopy can monitor dynamic cerebral autoregulation in adults. Neurocrit Care. 2009;10(1):122\u20138.","journal-title":"Neurocrit Care"},{"issue":"22","key":"2338_CR23","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1089\/neu.2017.5003","volume":"34","author":"X Liu","year":"2017","unstructured":"Liu X, Maurits NM, Aries MJH, et al. Monitoring of optimal cerebral perfusion pressure in traumatic brain injured patients using a multi-window weighting algorithm. J Neurotrauma. 2017;34(22):3081\u20138.","journal-title":"J Neurotrauma"},{"issue":"10","key":"2338_CR24","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","volume":"41","author":"MDI Vergouwen","year":"2010","unstructured":"Vergouwen MDI, Vermeulen M, van Gijn J, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies. Stroke. 2010;41(10):2391\u20135.","journal-title":"Stroke"},{"key":"2338_CR25","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1177\/0271678X231210430","volume":"44","author":"Y Wang","year":"2020","unstructured":"Wang Y, Payne SJ. Static autoregulation in humans. J Cereb Blood Flow Metab. 2024;44:1191\u2013207.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"2338_CR26","first-page":"169","volume":"27","author":"D Canova","year":"2013","unstructured":"Canova D, Roatta S, Micieli G, Bosone D. Cerebral oxygenation and haemodynamic effects induced by nimodipine in healthy subjects. Funct Neurol. 2013;27(3):169.","journal-title":"Funct Neurol"},{"issue":"4","key":"2338_CR27","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1152\/physrev.00022.2020","volume":"101","author":"JAHR Claassen","year":"2021","unstructured":"Claassen JAHR, Thijssen DHJ, Panerai RB, Faraci FM. Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation. Physiol Rev. 2021;101(4):1487.","journal-title":"Physiol Rev"},{"issue":"11","key":"2338_CR28","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1177\/0271678X241254676","volume":"44","author":"JA Claassen","year":"2024","unstructured":"Claassen JA. Shifting concepts of autoregulation: commentary to \u2018static autoregulation in humans.\u2019 J Cereb Blood Flow Metab. 2024;44(11):1397\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2338_CR29","doi-asserted-by":"publisher","first-page":"e501","DOI":"10.1016\/j.wneu.2021.11.016","volume":"158","author":"L Mahmoud","year":"2022","unstructured":"Mahmoud L, Zullo AR, Blake C, et al. Safety of modified nimodipine dosing in aneurysmal subarachnoid hemorrhage. World Neurosurg. 2022;158:e501\u20138.","journal-title":"World Neurosurg"},{"key":"2338_CR30","doi-asserted-by":"publisher","first-page":"e834","DOI":"10.1016\/j.wneu.2019.08.001","volume":"132","author":"S Hern\u00e1ndez-Dur\u00e1n","year":"2019","unstructured":"Hern\u00e1ndez-Dur\u00e1n S, Mielke D, Rohde V, Malinova V. Does nimodipine interruption due to high catecholamine doses lead to a greater incidence of delayed cerebral ischemia in the setting of aneurysmal subarachnoid hemorrhage? World Neurosurg. 2019;132:e834\u201340.","journal-title":"World Neurosurg"},{"issue":"4","key":"2338_CR31","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1161\/STROKEAHA.121.036139","volume":"53","author":"JS Minhas","year":"2022","unstructured":"Minhas JS, Moullaali TJ, Rinkel GJE, Anderson CS. Blood pressure management after intracerebral and subarachnoid hemorrhage: the knowns and known unknowns. Stroke. 2022;53(4):1065\u201373.","journal-title":"Stroke"},{"issue":"1","key":"2338_CR32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s12028-019-00676-w","volume":"31","author":"M Kieninger","year":"2019","unstructured":"Kieninger M, Gruber M, Knott I, et al. Incidence of arterial hypotension in patients receiving peroral or continuous intra-arterial nimodipine after aneurysmal or perimesencephalic subarachnoid hemorrhage. Neurocrit Care. 2019;31(1):32\u20139.","journal-title":"Neurocrit Care"},{"issue":"3","key":"2338_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0283180","volume":"18","author":"A Cattaneo","year":"2023","unstructured":"Cattaneo A, Wipplinger C, Geske C, et al. Investigating the relationship between high-dose norepinephrine administration and the incidence of delayed cerebral infarction in patients with aneurysmal subarachnoid hemorrhage: a single-center retrospective evaluation. PLoS ONE. 2023;18(3): e0283180.","journal-title":"PLoS ONE"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-025-02338-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-025-02338-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-025-02338-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T06:47:43Z","timestamp":1774594063000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-025-02338-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2338"],"URL":"https:\/\/doi.org\/10.1007\/s12028-025-02338-6","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"18 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"KAS, DB, SJ, PT, DV, JM-B, LMO, RH, CM, and NHP declare no competing interests. JK reports funding from the National Institute of Neurological Disorders and Stroke and the Brain Aneurysm Foundation. AdH has received consultant fees from Integra and Novo Nordisk and royalty fees from UpToDate and has equity in TitinKM and Certus. KNS reports compensation from Bexorg for consultant services; employment by Yale School of Medicine; compensation from Sense for data and safety monitoring services; compensation from Philips for data and safety monitoring services; compensation from Astrocyte for consultant services; stock holdings in AbbVie; compensation from Rhaeos for consultant services; stock options in BrainQ; a patent pending for Stroke wearables licensed to Alva Health; and grants from Hyperfine and Genentech. EJG reports funding from the National Institutes of Health (R01 NS117904). SO-G reports grants from the National Institutes of Health National Institute of Neurological Disorders and Stroke (RO1NS127114-01, RO1NS138765, RO3NS126804), PCORI, Stryker, Medtronic, and Methinks; consulting fees from Medtronic and Stryker Neurovascular; serving as overall principal investigator (PI) for US tandem Registry, DIRECT, DONE SYMPLE, and MAPSTROKE; serving as co-PI for VOTER registry, ATHENA, and SMART-LVO; serving as institutional PI and on the steering committee for SEGA, TESLA, ENDOLOW and SELECT 2, SPLENDID, SUMMIT, and MYSTIQUE; and stocks\/shares in Brainflow, Gravity, and Motif.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Ethical approval for this study was obtained from the institutional review board. Given the retrospective nature of the study and the minimal risk to participants, the requirement for individual informed consent was waived. This research was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval\/Informed Consent"}}]}}